1. What makes a microbial product a biostimulant?

Plant biostimulants are generally defined by function: they stimulate plant nutrition processes, stress tolerance, quality, or nutrient-use efficiency independently of their direct nutrient content. This separates them conceptually from conventional fertilisers and pesticides, although categories overlap in practice. A microorganism that increases phosphorus acquisition may be described as a biofertilizer; the same organism may be marketed as a biostimulant if the claim focuses on nutrient-use efficiency or abiotic stress (du Jardin, 2015).

Microbial products include plant growth-promoting rhizobacteria, mycorrhizal fungi, endophytes, and consortia. Their proposed effects include production or modulation of auxins and other hormones, reduction of stress ethylene through ACC deaminase, improved nutrient acquisition, exopolysaccharide production, induced systemic responses, and changes in root morphology. Backer et al. (2018) describe these mechanisms but also note the difficulty of translating them into reliable commercial performance.

The category should not be defined by a list of beneficial traits measured in vitro. A bacterium that produces auxin on laboratory medium may not produce a useful amount in the rhizosphere. A strain that tolerates osmotic stress may fail to colonise the crop. Product identity, formulation, dose, and application route are part of the biological mechanism because they determine whether the organism reaches the root alive.

2. How microbes may help plants under drought

Drought reduces water availability, nutrient diffusion, photosynthesis, and growth. Plants respond by changing stomata, roots, hormones, compatible solutes, and antioxidant systems. Microbes can modify several of these responses. ACC-deaminase-producing bacteria may reduce stress ethylene, allowing continued root growth. Auxin-producing strains can alter root branching. Exopolysaccharides may improve adhesion and microscale water retention. Mycorrhizal fungi can extend soil exploration and affect water relations.

Microbes may also prime plant defences, enabling a faster response when stress occurs. Some studies report higher proline, improved antioxidant enzyme activity, or altered expression of stress-related genes after inoculation. Vurukonda et al. (2016) reviewed numerous plant growth-promoting bacteria associated with drought tolerance. These mechanisms are plausible, but a biochemical change is not automatically agronomic benefit.

Drought timing matters. Protection during seedling establishment may not improve yield if flowering stress remains severe. Mild water limitation may reveal a biostimulant effect, while extreme drought overwhelms it. Recovery after rewatering can be as important as survival during stress. Trials should therefore define soil moisture, stress duration, growth stage, temperature, and irrigation regime rather than using “drought” as a single treatment.

3. Why field performance varies

Native soil communities compete with introduced organisms. Crop genotype determines root exudates and immune responses. Soil pH, texture, organic matter, salinity, and fertiliser use affect establishment. A formulation that works in moist, sterilised potting media may fail in hot field soil. Naylor and Coleman-Derr (2018) show that drought itself restructures root-associated bacterial communities, meaning the inoculant enters an ecosystem already changing under stress.

Storage and application create additional variation. Microbial cells may lose viability before use. Seed coating can expose them to desiccation or agrochemicals. Soil application requires adequate moisture for movement and colonisation. Consortia may lose members at different rates. If the applied population is unknown, a failed field trial cannot distinguish biological ineffectiveness from product death.

Publication bias also matters. Small pot experiments with positive outcomes are more likely to be published than neutral multi-season trials. Many studies measure biomass, chlorophyll, or root length rather than harvestable yield. A product intended for farmers should be tested across locations, seasons, and water regimes with economically relevant outcomes. Rouphael and Colla (2020) argue that biostimulant research must connect modes of action with field performance and quality standards.

4. Designing claims that evidence can support

A credible claim should specify crop, application method, stress context, and expected benefit. “Improves yield stability under moderate terminal drought in chickpea” is testable. “Makes all crops drought resistant” is not. Product labels should state microbial identity, viable count at expiry, storage conditions, compatibility, dose, and whether the evidence comes from greenhouse or field trials.

Trial design should include a well-watered control, a drought control, the biostimulant under both conditions, and relevant fertiliser or carrier controls. Soil moisture should be measured, not inferred from days without irrigation. Researchers should report absolute yield, variability, and failure sites. Multi-location trials can identify the environments in which the probability of benefit is high enough to justify cost.

India incorporated biostimulants into the Fertiliser (Control) Order framework, creating a route for product specifications and evidence (Ministry of Agriculture and Farmers Welfare, 2021). Implementation should distinguish microbial from non-microbial products and require methods suitable for live organisms. Post-market testing is necessary because viability can decline during distribution even when the initial batch met specifications.

5. A realistic role in climate-smart agriculture

Microbial biostimulants cannot replace water management, drought-tolerant varieties, soil organic matter, mulching, or appropriate sowing dates. They may complement these measures by improving root establishment, nutrient use, or recovery. Their greatest value may be probabilistic: reducing the magnitude of yield loss under defined moderate stresses rather than preventing crop failure under extreme drought.

Decision support could improve use. Soil type, crop, seasonal forecast, irrigation access, and product-specific trial data could help identify where application is likely to pay. Local production of well-characterised strains may reduce logistics problems, but decentralisation must not weaken quality control. Farmer-participatory trials can capture practical outcomes such as ease of use, compatibility with seed treatment, and return on investment.

The biology is real, but the promise must be bounded. Microorganisms influence plant drought responses, and some inoculants can improve performance. The sector will mature when success is defined as repeatable benefit in a known context, not the presence of a long list of laboratory traits. A microbial biostimulant should earn a drought-resilience claim through field evidence, viable product quality, and transparent limits.

6. From promising strains to recommendation zones

Biostimulant development could borrow the concept of recommendation zones from crop breeding. Instead of asking whether a product works nationally, researchers can identify environmental clusters defined by crop, soil, temperature, water regime, and management. Multi-location trials can then estimate the probability and magnitude of benefit within each cluster. A product might be recommended for rainfed sorghum on specific soil types but not for irrigated wheat, making the claim narrower and more useful.

Digital tools can support this approach only after adequate field data exist. Weather records, soil tests, irrigation schedules, and crop stage can be combined with product-specific trial results to advise timing and expected return. Models should report uncertainty and should be validated in seasons not used for training. A sophisticated prediction based on a few greenhouse studies would merely automate weak evidence.

Manufacturers should maintain reference samples and genomic records for commercial strains so that identity can be checked over time. Changes in fermentation, carrier, or supplier may alter performance even when the product name remains the same. Linking batch quality with geo-referenced field outcomes would allow the sector to learn why a product succeeds or fails and gradually replace generic drought claims with evidence-based recommendations.

7. What would count as success?

A successful drought biostimulant programme should show more than statistically significant differences in a few trials. It should demonstrate a repeatable probability of agronomic benefit, a viable product at the point of use, and a return that justifies farmer cost. Researchers can report the number needed to treat in agricultural terms: how many hectares must be treated to avoid one tonne of yield loss under a defined drought scenario. Such measures make variability visible and support comparison with mulching, irrigation scheduling, seed choice, or insurance. Products that work only under narrow conditions may still be valuable if those conditions can be identified. The objective is not universal performance but dependable recommendation. This standard would turn microbial biostimulants from broadly promoted biological optimism into measurable climate-risk tools.

8. Editorial perspective

The practical editorial conclusion is simple: biological plausibility should open a research programme, not close the argument. A drought claim becomes publishable and useful when the organism, product quality, stress definition, field environment, comparator, and economic outcome are described together. That standard protects farmers without dismissing microbial innovation and gives researchers clearer questions than asking whether “PGPR works” in general.